Industry Overview

Eye care surgical devices market was valued at $22.9 billion in 2025 and is projected to reach $37.4 billion by 2035, growing at a CAGR of 5.1% during the forecast Period (2026-2035). The market growth is driven by rising eye disorders (cataracts, glaucoma), an aging population needing vision correction, and tech innovations like lasers & IOLs for minimally invasive surgeries (MIS), expanding into more accessible centers. Its key drivers include demand for advanced cataract/glaucoma treatments, while challenges involve high device costs, limited reimbursement in some areas, and lack of awareness, but overall growth is strong due to unmet needs in emerging markets and better healthcare access.

Market Dynamic

Rising Prevalence of Vision Disorders

A major driver of the global eye care surgical devices market is the increasing incidence of ophthalmic conditions such as cataracts, glaucoma, diabetic retinopathy, and age-related macular degeneration (AMD). These conditions, particularly cataracts and glaucoma, are leading causes of visual impairment and blindness globally, prompting a growing number of patients to seek surgical treatment. As the global burden of these eye diseases increases due to factors such as diabetes prevalence and extended screen time use, demand for advanced surgical interventions and associated devices continues to rise. This sustained increase in surgical volume directly fuels adoption of technologies like phacoemulsification systems, laser surgery platforms, and glaucoma implants across clinical settings.

Technological Advancements in Surgical Devices

Another key driver is the rapid pace of technology innovation in ophthalmic surgery. Cutting-edge developments such as femtosecond laser systems, micro-invasive glaucoma surgery (MIGS) devices, 3D surgical visualization tools, and premium intraocular lenses (IOLs) are significantly improving surgical precision, patient outcomes, and recovery times. These technological improvements not only make procedures safer and more efficient but also broaden the range of treatable eye conditions and expand the surgeon and patient preference for advanced procedures. Additionally, AI integration and digital guidance systems are enhancing surgical planning and execution, further incentivizing healthcare providers to adopt modern eye care surgical equipment.

Aging Global Population and Increasing Surgical Demand

The ongoing global demographic shift toward an older population is a powerful long-term driver of market growth. Age is a significant risk factor for many vision-impairing diseases that require surgical intervention, especially cataracts and glaucoma. As life expectancy increases worldwide, the proportion of elderly individuals grows, resulting in higher surgical volumes year over year. For instance, the prevalence of age-related conditions such as cataracts and AMD escalates with advancing age, meaning nations with significant geriatric populations face rising demand for advanced eye surgeries. This demographic trend ensures sustained demand for eye care surgical devices over the coming decade, particularly in North America, Europe, and rapidly developing regions like the Asia-Pacific.

Market Segmentation

• Based on the type, the market is segmented into cataract surgical device, glaucoma surgical device, diabetic retinopathy surgical device, refractive surgical device, and vitreo-retinal surgical device.
• Based on the end-user, the market is segmented into diagnostic centres, hospitals, and eye care clinics.

Cataract Surgical Devices Segment to Grow at a Considerable Market Share

Cataract surgical devices used in hospitals represent the single largest segment leading the global eye care surgical devices market. Cataract surgery accounts for the highest surgical volume globally, as cataracts remain the most common cause of reversible blindness, particularly among the aging population. Hospitals dominate adoption due to their advanced surgical infrastructure, availability of trained ophthalmic surgeons, higher patient inflow, and capability to perform high-volume cataract procedures using sophisticated systems such as phacoemulsification platforms, femtosecond lasers, and premium intraocular lenses.

Additionally, hospitals are the primary centers for publicly funded and insurance-covered cataract surgeries in both developed and emerging economies, further consolidating their market share. The combination of high procedure frequency, technological intensity, and institutional purchasing power ensures that cataract surgical devices in hospital settings continue to command the largest share and lead overall market growth.

Hospitals: A Key Segment in Market Growth

Hospitals represent the single most important contributor to market growth in the global eye care surgical devices market. Hospitals continue to dominate due to their ability to manage high surgical volumes, particularly for cataract, glaucoma, and vitreoretinal procedures that require advanced infrastructure and multidisciplinary clinical support. Unlike diagnostic centres, which are primarily limited to screening and imaging, hospitals are equipped with fully integrated operating theatres, access to advanced phacoemulsification systems, femtosecond and excimer lasers, and post-operative care facilities, enabling them to perform complex and high-risk ophthalmic surgeries.

Additionally, hospitals are the preferred setting for patients with comorbidities such as diabetes and cardiovascular disease, where surgical interventions require continuous monitoring and specialized anesthetic support. The growth of hospitals as a key end-user is further reinforced by government funding, public–private partnerships, and insurance reimbursement coverage, particularly in developed and emerging healthcare systems. Large tertiary hospitals and teaching institutions also act as early adopters of innovative surgical technologies, driving faster penetration of next-generation devices. Moreover, increasing investments in hospital infrastructure across Asia-Pacific, the Middle East, and parts of Latin America are expanding access to advanced eye surgeries. As surgical backlogs rise and patient preference shifts toward comprehensive care under one roof, hospitals remain the primary growth engine for eye care surgical device adoption globally.

Regional Outlook

The global eye care surgical devices market is further divided by geography, including North America (the US and Canada), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), and the Rest of the World (the Middle East & Africa, and Latin America).

North America Region to Hold a Substantial Growth Rate

In North America, the US dominates the global Eye care surgical devices market, holding a major share due to its advanced healthcare infrastructure, high surgical volumes, and rapid adoption of innovative ophthalmic technologies. The country has a well-established network of hospitals, ambulatory surgical centers, and specialized eye care clinics that routinely perform cataract, glaucoma, refractive, and vitreoretinal surgeries. A high prevalence of age-related eye disorders, particularly cataracts, glaucoma, and diabetic retinopathy, combined with a rapidly aging population, continues to drive consistent demand for surgical interventions. The US also benefits from strong reimbursement frameworks under Medicare and private insurance, which significantly improve patient access to eye surgeries and encourage providers to invest in advanced surgical equipment.

Additionally, the presence of leading global manufacturers such as Alcon, Johnson & Johnson Vision, Bausch + Lomb, and Glaukos accelerates early adoption of next-generation technologies, including femtosecond laser systems, premium intraocular lenses, and micro-invasive glaucoma surgery (MIGS) devices. Continuous clinical research, surgeon training programs, and favorable regulatory pathways further strengthen the country’s leadership position. As a result, the United States remains the primary revenue-generating market for eye care surgical devices and continues to set global benchmarks for technological innovation and surgical standards in ophthalmology.

Market Players Outlook

The major companies operating in the global eye care surgical devices market include Alcon Inc., Bausch + Lomb, Carl Zeiss Meditec AG, Glaukos Corp., Johnson & Johnson Vision, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisitions to expand their businesses and develop innovative products to maintain their market positioning.

Recent Development

• In December 2025, the FDA approved the first Daily Disposable Soft Contact Lens for Presbyopia, the Deseyne lens, which features patented Extended Depth of Focus (EDOF) technology. It provides continuous focus across near, intermediate, and distance vision through a hyper-refractive central zone, offering a significant clinical advantage over traditional multifocal lenses that require extended adaptation.
• In October 2025, ZEISS Medical Technology launched enhancements to its ophthalmic product portfolio for the AAO 2025 conference, featuring updated diagnostic and surgical solutions like the ZEISS CIRRUS AngioPlex OCT-A, CLARUS 700 with ICGA imaging, and new DORC surgical instruments. Additional updates include CALLISTO eye software for the ZEISS ARTEVO 750 and 850, integrated cataract and glaucoma management solutions, and a preview of the Research Data Platform for clinical data collaboration. ZEISS also reported that over 12 million eyes have been treated using its SMILE and SMILE pro refractive technologies.
• In September 2025, Bausch + Lomb presented new scientific data at the ESCRS annual meeting in Copenhagen from September 12-16. Highlights include studies on LuxLife and enVista Aspire intraocular lenses, ELIOS glaucoma treatment, and new dry eye data from a multinational survey. Their exhibit at booth C2.025 will feature surgical innovations and product demonstrations, such as the Fully Digital SeeLuma Visualization Platform and the OCTAVIUS customized corneal treatment.
• In September 2024, Johnson & Johnson introduced the TECNIS Odyssey, an advanced intraocular lens (IOL) for cataract sufferers, providing broad vision across distances and lighting. This IOL achieves 93% of patients achieving freedom from glasses, offers greater tolerance to refractive errors, and ensures reliable surgical results. Compared to the PanOptix IOL, it enhances contrast in low light and allows reading of 14% smaller print, with 93% of patients experiencing minimal visual disturbances like halos or glare one month after surgery.

The Report Covers

• Market value data analysis for 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global eye care surgical devices market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.